Your browser doesn't support javascript.
loading
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates.
Schiavina, R; Borghesi, M; Brunocilla, E; Romagnoli, D; Diazzi, D; Giunchi, F; Vagnoni, V; Pultrone, C V; Dababneh, H; Porreca, A; Fiorentino, M; Martorana, G.
Afiliação
  • Schiavina R; 1] Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy [2] Postgraduate Speciality School of Specialization in Urology, University of Bologna, Bologna, Italy [3] Department of Specialistic, Diagnostic and Experimental Medicine, S Orsola-Malpighi Hospital, Univers
  • Borghesi M; 1] Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy [2] Doctorate in Cardiologic, Nephro-Urologic and Thoracic Science, University of Bologna, Bologna, Italy.
  • Brunocilla E; 1] Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy [2] Postgraduate Speciality School of Specialization in Urology, University of Bologna, Bologna, Italy [3] Department of Specialistic, Diagnostic and Experimental Medicine, S Orsola-Malpighi Hospital, Univers
  • Romagnoli D; Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Diazzi D; Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Giunchi F; Pathology Service, Addarii Institute of Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Vagnoni V; Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Pultrone CV; 1] Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy [2] Doctorate in Cardiologic, Nephro-Urologic and Thoracic Science, University of Bologna, Bologna, Italy.
  • Dababneh H; Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Porreca A; Department of Urology, Policlinico Abano Terme, Padua, Italy.
  • Fiorentino M; Pathology Service, Addarii Institute of Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Martorana G; 1] Department of Urology, S Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy [2] Postgraduate Speciality School of Specialization in Urology, University of Bologna, Bologna, Italy [3] Department of Specialistic, Diagnostic and Experimental Medicine, S Orsola-Malpighi Hospital, Univers
Prostate Cancer Prostatic Dis ; 18(3): 270-5, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26055663
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata Tipo de estudo: Guideline / Prognostic_studies / Screening_studies Aspecto: Patient_preference Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata Tipo de estudo: Guideline / Prognostic_studies / Screening_studies Aspecto: Patient_preference Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2015 Tipo de documento: Article País de publicação: Reino Unido